Inhaled Insulin: An Overview
Open Access
- 1 January 2001
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 19 (1) , 13-16
- https://doi.org/10.2337/diaclin.19.1.13
Abstract
In BriefKeywords
This publication has 7 references indexed in Scilit:
- Sustained efficacy and pulmonary safety of inhaled insulin during 2 years of outpatient therapyDiabetes Research and Clinical Practice, 2000
- New insulin replacement technologies: Overcoming barriers to tight glycemic controlCleveland Clinic Journal of Medicine, 1999
- Inhaled insulin1Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; Cmax, maximum serum concentration; Cmin, minimum serum concentration; Tmax, time of maximum serum concentration; NS, not significant; HbA1c, hemoglobin A1c; OA, oral agent; SD, standard deviation; MDI, metered dose inhaler; DPI, dry powder inhaler; MMAD, mass median aerodynamic diameter; CMC, critical micelle concentration; SR, sustained release; PLGA, poly lactic acid-co-glycolic acid; GI, gastrointestinal, GSD, geometric standard deviation; TLC, total lung capacity; VC, vital capacity; SMK, smokers; MW, molecular weight; MP, melting point.1Advanced Drug Delivery Reviews, 1999
- NOVEL FORMS OF INSULIN DELIVERYEndocrinology and Metabolism Clinics of North America, 1997
- Large Porous Particles for Pulmonary Drug DeliveryScience, 1997
- Insulin analoguesPostgraduate Medicine, 1997
- The Discovery of InsulinPublished by Springer Nature ,1982